This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Mylan Laboratories Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Narasimha Murty Pilli: Innovator in Pharmaceutical Formulations
Introduction
Narasimha Murty Pilli is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug formulations. His work focuses on enhancing the efficacy and stability of pharmaceutical compounds.
Latest Patents
Narasimha Murty Pilli holds a patent for "Polymorphic forms of sofosbuvir." This patent discloses a novel crystalline form of sofosbuvir, specifically form-M3, along with a process for its preparation. The crystalline sofosbuvir form-M3 may be beneficial in the formulation of pharmaceutical dosage forms, potentially improving the delivery and effectiveness of the drug.
Career Highlights
He is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create innovative pharmaceutical solutions. His contributions have been instrumental in advancing the company's product offerings.
Collaborations
Narasimha has collaborated with several professionals in his field, including Ramakoteswara Rao Jetti and Hemant Malhari Mande. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.
Conclusion
Narasimha Murty Pilli is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact the industry significantly. His innovative approach to drug development continues to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
